615 The impact of gender including female menopausal status on the safety and efficacy of immune checkpoint inhibitors

• Michael B Atkins,
• Neil J Shah,
• Jacob Zaemes,
• Andrew Pecora,
• Shaked Lev Ari,
• Lauren Pascual,
• Brittany Sinclaire,
• Alexandra DellaPia,
• Rachel A Zemel,
• Adil Alaoui,
• Andrew Ip,
• Deniz Ozisik,
• Ming Tan

Affiliations

Michael B Atkins

6Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA

Neil J Shah

Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA

Jacob Zaemes

Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, District of Columbia, USA

Andrew Pecora

Department of Oncology, John Theurer Cancer Center, Hackensack, New Jersey, USA

Shaked Lev Ari

1Georgetown University, Washington, DC, USA

Lauren Pascual

3John Theurer Cancer Center, Hackensack, NJ, USA

Brittany Sinclaire

3John Theurer Cancer Center, Hackensack, NJ, USA

Alexandra DellaPia

3John Theurer Cancer Center, Hackensack, NJ, USA

Rachel A Zemel

2MedStar Georgetown University Hospital, Washington, DC, USA

Adil Alaoui

4Innovation Center for Biomedical Informatics at Georgetown University, Washington, DC, USA

Andrew Ip

3John Theurer Cancer Center, Hackensack, NJ, USA

Deniz Ozisik

1Georgetown University, Washington, DC, USA

Ming Tan

1Georgetown University, Washington, DC, USA